ATE83267T1 - Hybridomen und monoklonale paratopische molekuele gegen apolipoprotein ai. - Google Patents

Hybridomen und monoklonale paratopische molekuele gegen apolipoprotein ai.

Info

Publication number
ATE83267T1
ATE83267T1 AT87308394T AT87308394T ATE83267T1 AT E83267 T1 ATE83267 T1 AT E83267T1 AT 87308394 T AT87308394 T AT 87308394T AT 87308394 T AT87308394 T AT 87308394T AT E83267 T1 ATE83267 T1 AT E83267T1
Authority
AT
Austria
Prior art keywords
paratopic molecules
hybridomes
molecules against
monoclonal paratopic
against apolipoprotein
Prior art date
Application number
AT87308394T
Other languages
English (en)
Inventor
Linda K Curtiss
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Application granted granted Critical
Publication of ATE83267T1 publication Critical patent/ATE83267T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT87308394T 1986-09-29 1987-09-22 Hybridomen und monoklonale paratopische molekuele gegen apolipoprotein ai. ATE83267T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/913,061 US5126240A (en) 1986-09-29 1986-09-29 Hybridomas and monoclonal paratopic molecules to apolipoprotein a-i
EP87308394A EP0266880B1 (de) 1986-09-29 1987-09-22 Hybridomen und monoklonale paratopische Moleküle gegen Apolipoprotein AI

Publications (1)

Publication Number Publication Date
ATE83267T1 true ATE83267T1 (de) 1992-12-15

Family

ID=25432895

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87308394T ATE83267T1 (de) 1986-09-29 1987-09-22 Hybridomen und monoklonale paratopische molekuele gegen apolipoprotein ai.

Country Status (17)

Country Link
US (1) US5126240A (de)
EP (1) EP0266880B1 (de)
JP (1) JP2505218B2 (de)
AT (1) ATE83267T1 (de)
AU (1) AU600975B2 (de)
CA (1) CA1309041C (de)
DE (1) DE3783015T2 (de)
DK (1) DK173174B1 (de)
ES (1) ES2051744T3 (de)
FI (1) FI92715C (de)
GR (1) GR3006843T3 (de)
IE (1) IE60130B1 (de)
IL (1) IL83937A (de)
NO (1) NO174004C (de)
NZ (1) NZ221938A (de)
PT (1) PT85826B (de)
ZA (1) ZA876973B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU621575B2 (en) * 1987-11-02 1992-03-19 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
JPH0264457A (ja) * 1988-08-31 1990-03-05 Nippon Shoji Kk 血清アポa−iの定量法
AU662885B2 (en) * 1990-06-07 1995-09-21 Scripps Research Institute, The APO AI polypeptides, antibodies, and immunoassays
AU9088891A (en) * 1990-11-29 1992-06-25 John E. Carbaugh Diagnostic and therapeutic compositions and methods for lipoprotein(a)
WO1994028422A1 (en) * 1993-05-28 1994-12-08 Ensys Environmental Products Inc. A polychlorinated biphenyls (pcb) immunoassay method, its components and a kit for use in performing the same
EP0659765A3 (de) * 1993-12-21 1995-09-27 Akzo Nobel Nv Immunorealitive Apo(a) Peptide.
US5786156A (en) * 1993-12-21 1998-07-28 Perimmune Holdings, Inc. Immunoreactive peptides of APO(A)
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
BR9609771A (pt) * 1995-07-21 1999-12-21 Trinity College Dublin Processo para medição quantitativa de proteìna amilóide a; proteìna recombinante; anti-soro especìfico de soro humano de fase aguda.
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
EP1412045A4 (de) * 2001-06-25 2007-05-02 Lipid Sciences Inc Ein lösungsmittel zur entfernung von lipiden aus fluiden verwendende systeme und verfahren
US7033500B2 (en) * 2001-06-25 2006-04-25 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
EP1409108A4 (de) * 2001-06-25 2007-11-14 Lipid Sciences Inc Hohlfaserberührungssysteme zur entfernung von lipiden aus fluiden
WO2003035691A1 (en) * 2001-10-26 2003-05-01 Xenon Genetics, Inc. Apolipoprotein a-i mutation useful for diagnosis and treatment of cardiovascular diseases
US20040106556A1 (en) * 2002-08-26 2004-06-03 Yanhong Zhu Method of treating and preventing alzheimer disease through administration of delipidated protein and lipoprotein particles
US7393826B2 (en) 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
CA2531227A1 (en) * 2003-07-03 2005-02-10 Lipid Sciences Inc. Methods and apparatus for creating particle derivatives of hdl with reduced lipid content
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
DE10353175A1 (de) * 2003-11-14 2005-06-16 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper mit fettsenkender Wirkung
CA3083194A1 (en) 2017-11-22 2019-05-31 Hdl Therapeutics, Inc. Systems and methods for priming fluid circuits of a plasma processing system
AU2018396009A1 (en) 2017-12-28 2020-07-16 Hdl Therapeutics, Inc. Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2455743A1 (fr) * 1979-05-02 1980-11-28 Goella Laboratoires Procede et dispositif pour le dosage des lipoproteines seriques
DE3269567D1 (en) * 1981-04-29 1986-04-10 Ciba Geigy Ag New devices and kits for immunological analysis
JPS60253871A (ja) * 1984-05-30 1985-12-14 Nippon Koutai Kenkyusho:Kk 抗アポa−1抗体
WO1986004144A1 (en) * 1984-12-31 1986-07-17 International Genetic Engineering, Inc. Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
US4677057A (en) * 1985-03-11 1987-06-30 Scripps Clinic And Research Foundation Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins
JPS6258997A (ja) * 1985-09-09 1987-03-14 Asahi Breweries Ltd モノクロ−ナル抗体

Also Published As

Publication number Publication date
PT85826B (pt) 1990-08-31
ZA876973B (en) 1988-03-21
ES2051744T3 (es) 1994-07-01
EP0266880A2 (de) 1988-05-11
DK490387A (da) 1988-03-30
EP0266880B1 (de) 1992-12-09
CA1309041C (en) 1992-10-20
AU7902987A (en) 1988-03-31
NO174004B (no) 1993-11-22
GR3006843T3 (de) 1993-06-30
NO174004C (no) 1994-03-02
FI874252L (fi) 1988-03-30
IE60130B1 (en) 1994-06-01
DE3783015T2 (de) 1993-04-15
DK173174B1 (da) 2000-02-28
FI92715C (fi) 1994-12-27
EP0266880A3 (en) 1989-05-24
DK490387D0 (da) 1987-09-18
NZ221938A (en) 1990-04-26
JPS63159398A (ja) 1988-07-02
AU600975B2 (en) 1990-08-30
FI92715B (fi) 1994-09-15
IL83937A (en) 1991-12-15
JP2505218B2 (ja) 1996-06-05
IL83937A0 (en) 1988-02-29
NO874055D0 (no) 1987-09-28
IE872502L (en) 1988-03-29
DE3783015D1 (de) 1993-01-21
PT85826A (en) 1987-10-01
US5126240A (en) 1992-06-30
NO874055L (no) 1988-03-30
FI874252A0 (fi) 1987-09-28

Similar Documents

Publication Publication Date Title
ATE83267T1 (de) Hybridomen und monoklonale paratopische molekuele gegen apolipoprotein ai.
GR3008027T3 (de)
AU7657387A (en) Apoprotein b-100 specific monoclonal antibodies
FR2491334B1 (de)
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
DE3787653D1 (de) Biotechnischer monitor zur kontinuierlichen bestimmung von schadwirkungen auf mikroorganismen in wasser.
FR2713434B1 (fr) Billonneur-sillonneur destiné à la culture de l'igname.
DE59009169D1 (de) Monoklonale, gegen ECA gerichtete Antikörper und ihre Verwendung.
SE9102618D0 (sv) Upphaengningsanordning
ITTO930277A0 (it) Macchina per la formazione di mazzette di segnature e simili articoli.
IT8124409A0 (it) Procedimento per la realizzazione di componenti per l'arredamento, in particolare mobiletti e simili, nonche' mobiletto ottenuto.
IT7922375U1 (it) Struttura di pannello stratificato particolarmente per pavimentazione, rivestimenti e simili.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time